Politics
FDA panel loosens restrictions for controversial peptides popular online
The vote marks a win for Health Secretary Robert F Kennedy who has said he's a big fan of the drugs, which haven't been well studied for human use.
An advisory panel for the US Food and Drug Administration (FDA) has voted to ease restrictions on certain controversial peptides, which have gained significant traction online despite limited research into their human applications.
The panel
health risksfdapeptidesonline wellnessdrug regulationbpckpvbiohacking